echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > In the digital age, what will the future of the pharmaceutical industry look like?

    In the digital age, what will the future of the pharmaceutical industry look like?

    • Last Update: 2020-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the data, China's pharmaceutical market sales have increased from 955.5 billion yuan in 2012 to 215 billion yuan (expected) in 2020, with a compound annual growth rate of 10.7%, and China's pharmaceutical market has maintained high and steady growth, although the traditional pharmaceutical model is still the main form of the industry.
    but there is no denying that, driven by policies and industries, the digitalization of medicine is being significantly improved, and traditional medicine is rapidly moving towards digitalization.
    development of the pharmaceutical industry involves the whole industry chain, multi-subject participation, including research and development, production and pharmaceutical circulation and other links.
    value level, the main goal of the digital development of the pharmaceutical industry is to empower scientific research, reconstruct business operations and optimize the user experience.
    digital solutions accelerate new drug development, increase productivity, reduce marketing costs, improve patient experience, and provide new impetus to the development of the pharmaceutical industry as a whole.
    from the current development of the pharmaceutical market, after several years of development of China's pharmaceutical industry digital has shown initial results, and began to enter the next stage.
    industry experts predict that the next stage of digital innovation in the pharmaceutical industry will mainly show three major trends.
    Pharmaceutical enterprises and digital enterprises integration accelerated in pharmaceutical enterprises around research and development, clinical research, production management, marketing and promotion of the integrated system completed the initial digital transformation process, pharmaceutical companies for digital productivity will further enhance the demand, from the use of generic products to customized demand evolution.
    digital enterprises that provide customized services to pharmaceutical companies may be able to integrate with each other through mergers and acquisitions, from providers of digital technology services to functions within pharmaceutical companies.
    big data mining and artificial intelligence technology complement each other and influence each other through the transformation of AI and big data digital results.
    artificial intelligence technology can dig new insights from structured big data and provide new ideas for enterprise development.
    , pharmaceutical companies that have achieved initial digitization have begun to accumulate their own operational data.
    these operational data will become part of the digital assets of pharmaceutical companies, laying the foundation for the next step in the development of pharmaceutical companies.
    When the amount of data accumulation reaches a certain threshold, pharmaceutical enterprises will have the ability to dig more valuable information from this data, realize the internal closed loop of operational data accumulation-mining data connotation-adjust the operation strategy of enterprises, so that enterprises can achieve exponential growth.
    pharmaceutical companies to accelerate the evolution of IT from pharmaceutical IT applications to pharmaceutical DT applications it is an acronym for Information Technology.
    IT era is based on self-control, self-management, and the DT (Data technology) era, it is to serve the masses, stimulate productivity-based technology.
    in the past, traditional pharmaceutical companies in the IT era, often because of the lack of grasp of business needs, from conversion to landing, often fall short of expectations.
    But with the change of policy, the flow trend of the drug market will be from the north to the broad grass-roots level, from the hospital gradually to the outside of the hospital, the digital development of pharmaceutical enterprises will also be patient-centered, connecting stakeholders to provide services for doctors and patients to further develop.
    conclusions, from medical devices, equipment networking, to hospitals, pharmacies management information, to medical services, health management personalized.
    growing signs that "digitalization" is helping the pharmaceutical industry "smartly transform" thanks to a number of high-tech franchises.
    future, digital medical ecology will become a hot spot in the development of the industry.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.